PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.975
+0.005 (0.13%)
Dec 22, 2025, 4:00 PM EST - Market closed
PolyPid Market Cap
PolyPid has a market cap or net worth of $66.12 million as of December 23, 2025. Its market cap has increased by 229.46% in one year.
Market Cap
66.12M
Enterprise Value
51.67M
1-Year Change
229.46%
Ranking
Category
Stock Price
$3.98
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $66.12M, a decrease of -19.79%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 66.12M | 219.71% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |